Cleared Traditional

K213987 - ARCHITECT HSV-1 IgG, ARCHITECT HSV-1 IgG Calibrator, ARCHITECT HSV-1 IgG Controls (FDA 510(k) Clearance)

Sep 2023
Decision
639d
Days
Class 2
Risk

K213987 is an FDA 510(k) clearance for the ARCHITECT HSV-1 IgG, ARCHITECT HSV-1 IgG Calibrator, ARCHITECT HSV-1 IgG Controls. This device is classified as a Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1 (Class II - Special Controls, product code MXJ).

Submitted by Biokit, S.A. (Lliçà D´Amunt, ES). The FDA issued a Cleared decision on September 20, 2023, 639 days after receiving the submission on December 20, 2021.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3305.

Submission Details

510(k) Number K213987 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date September 20, 2023
Days to Decision 639 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code MXJ — Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3305